Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen ovarian cancer drug fails to improve overall survival
Amgen ovarian cancer drug fails to improve overall survival
Amgen ovarian cancer drug fails to improve overall survival
Submitted by
admin
on November 4, 2014 - 10:30am
Source:
Reuters
News Tags:
Amgen
ovarian cancer
trebananib
Headline:
Amgen ovarian cancer drug fails to improve overall survival
Do Not Allow Advertisers to Use My Personal information
